Concepedia

Xiaojing Zhang

XZ

Statistics

Publications

56

Citations

2.3K

H-Index

26

Active since

2005

Affiliations

Shenzhen University(Current)

Sidney Kimmel Comprehensive Cancer Center

Shenzhen Institutes of Advanced Technology

Johns Hopkins University

Peking University

Xiaojing Zhang is an author at Shenzhen University specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2005–2024

56

Publications

56

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Jie Wang, Caicun Zhou, Wenxiu Yao et al. · The Lancet Oncology · 2022 · 361 citations

, , +5

Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate

Chad D. Knights, Jason Catania, Simone Di Giovanni et al. · The Journal of Cell Biology · 2006 · 274 citations · Full text

A novel protein AXIN1-295aa encoded by circAXIN1 activates the Wnt/β-catenin signaling pathway to promote gastric cancer progression

Yin Peng, Yidan Xu, Xiaojing Zhang et al. · Molecular Cancer · 2021 · 188 citations · Full text

MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU

Yin Peng, Xiaojing Zhang, Qiang Ma et al. · Cancer Letters · 2016 · 82 citations

, , +11

Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial

Dan Liu, Jun Zhou, Yongsheng Wang et al. · BMC Medicine · 2022 · 73 citations · Full text

Rows per page

1–5 of 56